LEMTRADA
Concentrate for solution for infusion, 12mg
HospitalActive license
Active substance (INN)
alemtuzumab
Pharmaceutical form
Pharmaceutical formConcentrate for solution for infusion
Strength12mg
PackagingUkupno 1 bočica, staklena sa 1.2ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerGenzyme Ltd., United Kingdom
Therapeutic groupAntineoplastic and immunomodulating agents (L04AG06)
Marketing authorization holderAMICUS PHARMA DOO PODGORICA
Authorization dateApril 17, 2015
Source: CInMED register